LCTX logo

Lineage Cell Therapeutics (LCTX) Stock Relative Strength Index

14-day RSI

32.68
-2.09-6.01%

27 November 2024

LCTX RSI Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LCTX RSI Performance

PeriodPeriod14-day RSI14-day RSIPricePrice50-day SMA50-day SMA200-day SMA200-day SMA
todaytoday-6.0%+5.9%-0.7%-0.2%
1 m1 month-35.2%-31.2%-4.5%-2.5%
3 m3 months-28.6%-35.0%-9.9%-5.7%
6 m6 months-10.8%-36.4%-29.5%-13.8%
ytdytd-38.5%-45.1%-19.6%-22.1%
1 y1 year-28.3%-40.1%-25.6%-24.1%
5 y5 years-40.5%-33.5%-6.5%-8.0%

LCTX RSI High & Low

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1 month60.78-46.2%22.22+47.1%
3 m3 months60.78-46.2%22.22+47.1%
6 m6 months64.37-49.2%22.22+47.1%
1 y1 year67.17-51.4%22.22+47.1%
3 y3 years69.69-53.1%22.22+47.1%
5 y5 years87.90-62.8%21.18+54.3%
alltimeall time93.04-64.9%6.22+425.4%

Lineage Cell Therapeutics Stock RSI History

DateValue
2024
32.68(-38.5%)
2023
53.10(+19.2%)
2022
44.55(-17.3%)
2021
53.88(-11.6%)
2020
60.98(-2.0%)
2019
62.20(+159.2%)
2018
24.00(-18.9%)
2017
29.61(-42.0%)
2016
51.04(-11.8%)
2015
57.86(-4.6%)
2014
60.66(+25.8%)
2013
48.21(+39.9%)
2012
34.46(-46.9%)
2011
64.94(+33.9%)
2010
48.49(+6.0%)
2009
45.74(-1.8%)
DateValue
2008
46.56(-1.8%)
2007
47.43(+2.1%)
2006
46.47(-16.8%)
2005
55.87(-10.0%)
2004
62.08(+51.2%)
2003
41.06(-20.9%)
2002
51.88(+12.6%)
2001
46.06(-16.7%)
2000
55.29(+38.2%)
1999
40.01(-43.8%)
1998
71.20(+66.2%)
1997
42.85(-33.1%)
1996
64.01(+20.1%)
1995
53.29(+10.7%)
1994
48.15(+22.3%)
1993
39.37(-32.4%)
1992
58.28

FAQ

  • What is Lineage Cell Therapeutics 14-day relative strength index?
  • What is the all time high 14-day RSI for Lineage Cell Therapeutics?

What is Lineage Cell Therapeutics 14-day relative strength index?

The current 14-day RSI of LCTX is 32.68

What is the all time high 14-day RSI for Lineage Cell Therapeutics?

Lineage Cell Therapeutics all-time high 14-day relative strength index is 93.04